Spinal Implant Maker Can Liquidate Under Ch. 11 Plan

By Clara Geoghegan · June 20, 2024, 7:05 PM EDT

A Delaware bankruptcy judge agreed Thursday to approve the Chapter 11 liquidation and wind-down plan of biotechnology developer InVivo, which reported it landed a buyer for its spinal cord implant technology...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

Biotechnology firm InVivo Therapeutics Corp. sought bankruptcy protections, saying it plans to sell its assets and wind down after abandoning the development of its primary product, an implant to treat spinal cord injuries.

Case Number

24-bk-10137

Judge

Mary F. Walrath

Venue

U.S. Bankruptcy Court for the District of Delaware

Capital Structure

Total Liabilities:

$666,000

View Full Scorecard

Related Sections

Case Information

Case Title

InVivo Therapeutics Corporation

Case Number

1:24-bk-10137

Court

Delaware

Nature of Suit

Date Filed

February 01, 2024

Recent Articles By Clara